title: Decreased bone mineralization in children with phenylketonuria under treatment.
abstract: Children with phenylketonuria (PKU) obtain a great deal of their protein and mineral intakes from synthetic elemental formulae devoid of phenylalanine. To assess the effect of such diets and/or the disease on bone mineralization, children with PKU were compared to normal children for many parameters of mineral homeostasis and bone mineralization. A total of 11 children with PKU of mean age 10.9 +/- 4.2 years were compared to a large group of normal control children mean age 11.4 +/- 4.2, and an age and sex matched subset (n = 11). Children with PKU had lower serum calcium (9.1 +/- 0.9 vs 10.4 +/- 1.9 mg/dl P < 0.01) amd magnesium (1.67 +/- 1.4 vs 2.07 +/- 0.16 mg/ dl, P < 0.001) but normal values for phosphorus, zinc, and copper. The percentage tubular reabsorption of phosphorus was increased in PKU (93 +/- 3% vs 88 +/- 6%, P < 0.05) suggesting a lower phosphorus intake and/or absorption. Serum 25-hydroxyvitamin D, parathyroid hormone and 1,25 dihydroxyvitamin D were similar in PKU and control children. Serum albumin and lean body mass by dual energy X-ray absorption were not different suggesting that protein intake was adequate. In the 11 pairs, a decreased bone mineral density was seen for the lumbar spine (0.61 +/- 0.15 vs 0.72 +/- 0.24 P < 0.05), and lower extremities (1.56 +/- 0.30 vs 1.87 +/- 0.56 P < 0.05) by paired t-test. Compared to the total controls and the paired controls, decreases were seen in markers of bone formation; bone alkaline phosphatase, (72 +/- 30 vs 126 +/- 43 P < 0.001), osteocalcin (10.7 +/- 3.4 vs 13.1 +/- 2.0 P < 0.05) and procollagen type I carboxyterminal propeptide. No differences were seen in the bone resorption markers tartrate resistant acid phosphatase and urine Ca/Cr. The changes noted could not be related after age correction to serum phenylalanine levels, protein intake, or mineral intakes. It is unclear whether deficits in bone mineralization relate to the disease process itself or its treatment.
authors.affiliation: Department of Child Health, Columbia, MO 65212, USA.
authors.forename: L
authors.initials: L
authors.lastname: Hillman
authors.forename: C
authors.initials: C
authors.lastname: Schlotzhauer
authors.forename: D
authors.initials: D
authors.lastname: Lee
authors.forename: J
authors.initials: J
authors.lastname: Grasela
authors.forename: S
authors.initials: S
authors.lastname: Witter
authors.forename: S
authors.initials: S
authors.lastname: Allen
authors.forename: R
authors.initials: R
authors.lastname: Hillman
mesh_terms: D000293:Adolescent; D000367:Age Factors; D015519:Bone Density; D002113:Calcification, Physiologic; D002118:Calcium / Q000097:blood; D002648:Child; D003404:Creatinine / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D016555:Matched-Pair Analysis; D010661:Phenylketonurias / Q000178:diet therapy* / Q000503:physiopathology*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism; D012737:Sex Factors; D014131:Trace Elements / Q000378:metabolism
chemical_list: D014131:Trace Elements; D003404:Creatinine; D010744:Phosphoric Monoester Hydrolases; D002118:Calcium